PHARMACEUTICAL BUSINESS REGULATION IN GEORGIA ACCORDING TO THE EUROPEAN UNION STANDARDS

International regulations are intensively introduced in the pharmaceutical activity of Georgia, which is the tendency of the world pharmaceutical business. The pharmaceutical market of Georgia is growing at a fast pace every year and is a very profitable field.

The European Union's pharmaceutical strategy is the development of the pharmaceutical industry and business operations, also reducing the prices of medicines and their availability is of great importance.

The GMP/GDP standards ensure the high quality of pharmaceutical products in circulation and, at the same time, increase the country's export potential. According to the international standards of the European Union, GMP - Good Manufacturing Practice is a system that outlines the production and quality control of pharmaceutical products under standards. Georgia has recently begun implementing Good Distribution Practice (GDP) in pharmaceutical activities. In Georgia, the transition to the GMP/GDP standard is mandatory for all pharmaceutical enterprises and wholesale distributors.